Logo image of AXON

AXON ENTERPRISE INC (AXON) Stock Fundamental Analysis

NASDAQ:AXON - Nasdaq - US05464C1018 - Common Stock - Currency: USD

872.705  +5.59 (+0.64%)

Fundamental Rating

5

AXON gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 67 industry peers in the Aerospace & Defense industry. AXON has only an average score on both its financial health and profitability. AXON is valued quite expensive, but it does show an excellent growth. With these ratings, AXON could be worth investigating further for growth investing!.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

AXON had positive earnings in the past year.
AXON had a positive operating cash flow in the past year.
In multiple years AXON reported negative net income over the last 5 years.
In the past 5 years AXON always reported a positive cash flow from operatings.
AXON Yearly Net Income VS EBIT VS OCF VS FCFAXON Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M 400M

1.2 Ratios

Looking at the Return On Assets, with a value of 5.25%, AXON is in the better half of the industry, outperforming 70.15% of the companies in the same industry.
AXON has a better Return On Equity (11.94%) than 77.61% of its industry peers.
Industry RankSector Rank
ROA 5.25%
ROE 11.94%
ROIC N/A
ROA(3y)6.24%
ROA(5y)3.01%
ROE(3y)12.89%
ROE(5y)6.55%
ROIC(3y)N/A
ROIC(5y)N/A
AXON Yearly ROA, ROE, ROICAXON Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10 15

1.3 Margins

Looking at the Profit Margin, with a value of 13.64%, AXON belongs to the top of the industry, outperforming 89.55% of the companies in the same industry.
AXON's Profit Margin has improved in the last couple of years.
With an excellent Gross Margin value of 60.47%, AXON belongs to the best of the industry, outperforming 92.54% of the companies in the same industry.
AXON's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 13.64%
GM 60.47%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y155.54%
GM growth 3Y-1.64%
GM growth 5Y0.59%
AXON Yearly Profit, Operating, Gross MarginsAXON Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

6

2. Health

2.1 Basic Checks

AXON does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AXON has been increased compared to 1 year ago.
Compared to 5 years ago, AXON has more shares outstanding
AXON has a better debt/assets ratio than last year.
AXON Yearly Shares OutstandingAXON Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
AXON Yearly Total Debt VS Total AssetsAXON Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

An Altman-Z score of 12.71 indicates that AXON is not in any danger for bankruptcy at the moment.
AXON's Altman-Z score of 12.71 is amongst the best of the industry. AXON outperforms 89.55% of its industry peers.
AXON has a debt to FCF ratio of 11.38. This is a negative value and a sign of low solvency as AXON would need 11.38 years to pay back of all of its debts.
The Debt to FCF ratio of AXON (11.38) is better than 61.19% of its industry peers.
A Debt/Equity ratio of 0.63 indicates that AXON is somewhat dependend on debt financing.
AXON has a Debt to Equity ratio of 0.63. This is in the lower half of the industry: AXON underperforms 61.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 11.38
Altman-Z 12.71
ROIC/WACCN/A
WACC9.91%
AXON Yearly LT Debt VS Equity VS FCFAXON Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 2.95 indicates that AXON has no problem at all paying its short term obligations.
AXON has a Current ratio of 2.95. This is in the better half of the industry: AXON outperforms 65.67% of its industry peers.
A Quick Ratio of 2.71 indicates that AXON has no problem at all paying its short term obligations.
AXON's Quick ratio of 2.71 is amongst the best of the industry. AXON outperforms 82.09% of its industry peers.
Industry RankSector Rank
Current Ratio 2.95
Quick Ratio 2.71
AXON Yearly Current Assets VS Current LiabilitesAXON Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

More info and screens

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 57.24% over the past year.
AXON shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 41.41% yearly.
The Revenue has grown by 32.37% in the past year. This is a very strong growth!
Measured over the past years, AXON shows a very strong growth in Revenue. The Revenue has been growing by 31.44% on average per year.
EPS 1Y (TTM)57.24%
EPS 3Y36.34%
EPS 5Y41.41%
EPS Q2Q%76.67%
Revenue 1Y (TTM)32.37%
Revenue growth 3Y34.11%
Revenue growth 5Y31.44%
Sales Q2Q%32.62%

3.2 Future

AXON is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.98% yearly.
The Revenue is expected to grow by 19.50% on average over the next years. This is quite good.
EPS Next Y7.3%
EPS Next 2Y15.28%
EPS Next 3Y15.98%
EPS Next 5YN/A
Revenue Next Year28.26%
Revenue Next 2Y25.79%
Revenue Next 3Y23.51%
Revenue Next 5Y19.5%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
AXON Yearly Revenue VS EstimatesAXON Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B
AXON Yearly EPS VS EstimatesAXON Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

AXON is valuated quite expensively with a Price/Earnings ratio of 123.61.
Compared to the rest of the industry, the Price/Earnings ratio of AXON is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 27.03. AXON is valued rather expensively when compared to this.
The Price/Forward Earnings ratio is 111.69, which means the current valuation is very expensive for AXON.
Based on the Price/Forward Earnings ratio, AXON is valued a bit more expensive than the industry average as 65.67% of the companies are valued more cheaply.
AXON is valuated expensively when we compare the Price/Forward Earnings ratio to 36.28, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 123.61
Fwd PE 111.69
AXON Price Earnings VS Forward Price EarningsAXON Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AXON is valued a bit more expensive than the industry average as 64.18% of the companies are valued more cheaply.
AXON's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 384.95
EV/EBITDA 1106.1
AXON Per share dataAXON EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as AXON's earnings are expected to grow with 15.98% in the coming years.
PEG (NY)16.94
PEG (5Y)2.99
EPS Next 2Y15.28%
EPS Next 3Y15.98%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AXON!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AXON ENTERPRISE INC

NASDAQ:AXON (8/6/2025, 12:16:57 PM)

872.705

+5.59 (+0.64%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)08-04 2025-08-04/amc
Earnings (Next)11-05 2025-11-05/amc
Inst Owners81.97%
Inst Owner ChangeN/A
Ins Owners0.58%
Ins Owner Change6.11%
Market Cap67.94B
Analysts81.54
Price Target810.86 (-7.09%)
Short Float %2.05%
Short Ratio2.59
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)25.34%
Min EPS beat(2)8.51%
Max EPS beat(2)42.17%
EPS beat(4)4
Avg EPS beat(4)28.65%
Min EPS beat(4)8.51%
Max EPS beat(4)45.27%
EPS beat(8)8
Avg EPS beat(8)26.23%
EPS beat(12)12
Avg EPS beat(12)33.52%
EPS beat(16)16
Avg EPS beat(16)60.63%
Revenue beat(2)2
Avg Revenue beat(2)2.58%
Min Revenue beat(2)1.38%
Max Revenue beat(2)3.78%
Revenue beat(4)3
Avg Revenue beat(4)1.6%
Min Revenue beat(4)-0.39%
Max Revenue beat(4)3.78%
Revenue beat(8)7
Avg Revenue beat(8)2.04%
Revenue beat(12)11
Avg Revenue beat(12)3.55%
Revenue beat(16)15
Avg Revenue beat(16)4.85%
PT rev (1m)4.1%
PT rev (3m)12.64%
EPS NQ rev (1m)0.08%
EPS NQ rev (3m)1.26%
EPS NY rev (1m)-0.05%
EPS NY rev (3m)1.51%
Revenue NQ rev (1m)-1.51%
Revenue NQ rev (3m)-0.26%
Revenue NY rev (1m)0.15%
Revenue NY rev (3m)1.8%
Valuation
Industry RankSector Rank
PE 123.61
Fwd PE 111.69
P/S 28.41
P/FCF 384.95
P/OCF 246.54
P/B 24.86
P/tB 37.59
EV/EBITDA 1106.1
EPS(TTM)7.06
EY0.81%
EPS(NY)7.81
Fwd EY0.9%
FCF(TTM)2.27
FCFY0.26%
OCF(TTM)3.54
OCFY0.41%
SpS30.72
BVpS35.1
TBVpS23.22
PEG (NY)16.94
PEG (5Y)2.99
Profitability
Industry RankSector Rank
ROA 5.25%
ROE 11.94%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 13.64%
GM 60.47%
FCFM 7.38%
ROA(3y)6.24%
ROA(5y)3.01%
ROE(3y)12.89%
ROE(5y)6.55%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)3.99%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y155.54%
GM growth 3Y-1.64%
GM growth 5Y0.59%
F-Score4
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 11.38
Debt/EBITDA 29.12
Cap/Depr 163.86%
Cap/Sales 4.14%
Interest Coverage N/A
Cash Conversion 464.18%
Profit Quality 54.09%
Current Ratio 2.95
Quick Ratio 2.71
Altman-Z 12.71
F-Score4
WACC9.91%
ROIC/WACCN/A
Cap/Depr(3y)192.5%
Cap/Depr(5y)286.11%
Cap/Sales(3y)4.12%
Cap/Sales(5y)5.78%
Profit Quality(3y)94.26%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)57.24%
EPS 3Y36.34%
EPS 5Y41.41%
EPS Q2Q%76.67%
EPS Next Y7.3%
EPS Next 2Y15.28%
EPS Next 3Y15.98%
EPS Next 5YN/A
Revenue 1Y (TTM)32.37%
Revenue growth 3Y34.11%
Revenue growth 5Y31.44%
Sales Q2Q%32.62%
Revenue Next Year28.26%
Revenue Next 2Y25.79%
Revenue Next 3Y23.51%
Revenue Next 5Y19.5%
EBIT growth 1Y-100.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year95.57%
EBIT Next 3Y48.75%
EBIT Next 5YN/A
FCF growth 1Y59.92%
FCF growth 3Y64.36%
FCF growth 5Y46.2%
OCF growth 1Y74.03%
OCF growth 3Y48.58%
OCF growth 5Y44.12%